Injective INJ
Current Price
$4.33 +4.85%
$0.2700 Daily Range (6.24%)
$4.12$4.39
$65.98M Daily Volume
815 BTC
Vol/MktCap: 15.26%
Market Performance
0.19% Relative BTC Volume
The total volume of Injective is $65.98M over the past 24 hours, compared to $35.50B total Bitcoin volume.
Hourly Moving Average
8 SMA $4.25 +1.77%
13 SMA $4.27 +1.38%
21 SMA $4.24 +2.21%
55 SMA $4.22 +2.51%
144 SMA $4.02 +7.72%
Price Performance
+1.23% 1 Hour Change
$4.33 from $4.28
+14.19% 7 Day Change
$0.6143 from $3.72
+18.06% 14 Day Change
$0.7819 from $3.55
+43.38% 30 Day Change
$1.88 from $2.45
All Time High
March 14, 2024
$52.62 -91.77%
-$48.29 vs. now
24H Change
19.01M USD +4.60%
235 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
15.51M INJ
traded over past 24 hours
15.51% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $4.34, experiencing a 4.97% increase in the last 24 hours. The daily trading range has been relatively tight, with a high of $4.39 and a low of $4.12, reflecting a 0.27% volatility in the price movement.
The trading volume stands at approximately $65.27 million, with a volume-to-market cap ratio of 15.01%, indicating healthy market activity. Technical indicators show short-term upward momentum; the 8 SMA is at $4.25 with a 2.01% increase, while the 21 SMA shows a stronger growth of 2.44%, suggesting bullish sentiment in the immediate term.
The Relative Strength Index (RSI) readings are also positive, with the 1-hour RSI at 57 and the 7-day RSI at 58, which indicates that INJ is neither overbought nor oversold. Over the past 30 days, the price has surged by 44.06%, supported by a solid upward trend reflected in the 14-day price change of 18.12%.
Injective's all-time high of $52.62 was reached on March 14, 2024, suggesting significant long-term potential. However, the current price remains substantially below that level, providing a favorable entry point for investors looking to capitalize on future price appreciation.
Given the positive short-term momentum, healthy volume, and favorable RSI indicators, the outlook for Injective is bullish. Therefore, I recommend a Buy rating on INJ, as the asset shows strong potential for upward movement in the near term.
The trading volume stands at approximately $65.27 million, with a volume-to-market cap ratio of 15.01%, indicating healthy market activity. Technical indicators show short-term upward momentum; the 8 SMA is at $4.25 with a 2.01% increase, while the 21 SMA shows a stronger growth of 2.44%, suggesting bullish sentiment in the immediate term.
The Relative Strength Index (RSI) readings are also positive, with the 1-hour RSI at 57 and the 7-day RSI at 58, which indicates that INJ is neither overbought nor oversold. Over the past 30 days, the price has surged by 44.06%, supported by a solid upward trend reflected in the 14-day price change of 18.12%.
Injective's all-time high of $52.62 was reached on March 14, 2024, suggesting significant long-term potential. However, the current price remains substantially below that level, providing a favorable entry point for investors looking to capitalize on future price appreciation.
Given the positive short-term momentum, healthy volume, and favorable RSI indicators, the outlook for Injective is bullish. Therefore, I recommend a Buy rating on INJ, as the asset shows strong potential for upward movement in the near term.
Updated 53 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
You May Also Like
In The News

Goldman Sachs delays Fed rate cut outlook to December 2026 amid inflation pressures
Prolonged high rates may tighten financial liquidity, impacting crypto markets and potentially strengthening the US dollar, affecting global demand.

Goldman Sachs sees Chinese yuan 20% undervalued, raises forecasts
Goldman's yuan forecast suggests potential shifts in global trade dynamics and investment strategies, impacting currency markets and economic policies.

Bitcoin rallies 2.3% after Trump calls Iran peace proposal ‘totally unacceptable’
10x Research CEO Markus Thielen said Bitcoin’s strength above $80,000 could be supported by two favorable decisions in the US Senate this week.

Are altcoins heading for a crash? – How a $2.6B leverage spike raises risk
Altcoin overleverage signals fragile market structure amid weak conviction.